Article
Interferon alpha-based combinations suppress SARS-CoV-2 infection in vitro and in vivo
2021-01-05
Abstract excerpt
There is an urgent need for new antivirals with powerful therapeutic potential and tolerable side effects. In the present study, we found that recombinant human interferon-alpha (IFNa) triggers intrinsic and extrinsic cellular antiviral responses, as well as reduces replication of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in vitro. Although IFNa alone was insufficient to completely abolish SARS-...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e2ed6b24-8091-5ac6-ad66-69d689eb7891
- DOI
- 10.1101/2021.01.05.425331
